SOUTHWEST ONCOLOGY GROUP

描述(改编自申请者摘要)：韦恩州立大学 (WSU)一直是西南肿瘤学的活跃机构成员 该集团已有25年的历史，招募了4500多名患者参加临床试验。 多年来，他们的教职员工在支持 SWOG，通过在行政和科学职能方面提供领导 SWOG，也通过在一个 持续一致的态度。因此，西澳州立大学一直保持在第一位。 SWOG在每一年进行的机构绩效评估的四分之一 在过去的五年里。威斯康星州立大学的癌症临床研究计划 是按照多学科疾病导向研究的思路组织的 并以一种类似于SWOG机构委员会导向的方式。 因此，他们在SWOG科学委员会中的教职员工代表是 由对这些领域具有专业知识和承诺的个人组成 研究的成果。因此，将思想转化为SWOG研究如下 以及纳入SWOG研究和NCI指定的高 将优先试验转变为WSU治疗优先事项很容易。在……里面 此外，他们所在地区的人口结构和 研究人员向所有患者提供临床试验显然是 在招募少数族裔(33%)和妇女(46%)时发现 百分比)进入SWOG临床试验。休斯敦州立大学的SWOG成员资格和 其教职员工参与学科的多样性持续增长。 这些年来。到目前为止，WSU的87名成员目前在38 委员会。同样，60项SWOG研究将WSU成员列为研究对象 自上一次竞争申请以来担任主席或研究协调员 已提交。劳伦斯·弗莱厄蒂博士，自1986年以来一直是SWOG成员 SWOG黑色素瘤委员会副主席成为负责人 在曼纽尔博士离任时，这一竞争性更新的调查员 瓦尔迪维索加盟了另一家机构。他将保持西苏里州立大学的突出地位 作为SWOG成员机构。

Description (Adapted from the applicant's abstract): Wayne State University (WSU) has been an active institutional member of the Southwest Oncology Group for over 25 years, enrolling over 4500 patients onto clinical trials. Over these years, their faculty have played an important role in support of SWOG, by providing leadership in the administrative and scientific functions of SWOG, and also by meeting and exceeding patient accrual goals in a continuous and consistent manner. Thus, WSU has remained in the first quartile of institution's performance evaluation conducted by SWOG in each of the last five years. The clinical research program in cancer at WSU has been organized along the lines of multidisciplinary disease oriented studies and in a manner which resembles the organ committee orientation of SWOG. Thus, their faculty's representation in scientific SWOG committees is constituted by individuals with expertise and commitment towards those areas of research. Accordingly, the translation of ideas into SWOG studies as well as the incorporation of SWOG studies and those of NCI designated high priority trials into WSU treatment priorities, are easily facilitated. In addition, the demographics of their region and the commitment of investigators to make clinical trials available to all patients, is clearly identified in their recruitment of minorities (33 percent) and women (46 percent) into SWOG clinical trials. The SWOG membership in WSU and the diversity of disciplinary involvement by their faculty has continued to grow over the years. To date, 87 WSU members are currently serving on 38 committees. Similarly, 60 SWOG studies list a WSU member as a study chairman or as study coordinator since the last competing application was submitted. Dr. Lawrence Flaherty, a SWOG member since 1986 and Vice-Chairman of the SWOG Melanoma Committee, becomes the Principal Investigator of this competing renewal at the departure of Dr. Manuel Valdivieso for another institution. He will maintain the prominence of WSU as a SWOG member institution.